Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_assertion type Assertion NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_head.
- NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_assertion description "[We assessed the safety and efficacy of protease inhibitor-based triple therapy in patients with recurrent advanced fibrosis and cholestatic hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_provenance.
- NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_assertion evidence source_evidence_literature NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_provenance.
- NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_assertion SIO_000772 25715116 NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_provenance.
- NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_assertion wasDerivedFrom befree-2016 NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_provenance.
- NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_assertion wasGeneratedBy ECO_0000203 NP1266280.RANv5b30tHs_vVBnVwDVOIlD17tDbgc-pEIIxNW1F-qzg130_provenance.